SCHEMBL7048760

SCHEMBL7048760

CCOc1ccc(S(=O)(=O)N2CCNCC2N2CCN(CCCF)CC2)cc1C(=O)Nc1c(CC)cn(C)c1C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
PDE5A O76074 3/20 0.35
LMNA P02545 2/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
MET P08581 1/20 0.32
CREBBP Q92793 1/20 0.31
TSPO P30536 2/20 0.31
MRGPRX1 Q96LB2 2/20 0.31
TSHR P16473 1/20 0.31
MMP1 P03956 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31
ADAM17 P78536 1/20 0.31
THRB P10828 1/20 0.30
TP53 P04637 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7056316 0.96 KMT2A (0.35) KMT2AMEN1PDE5ALMNAPOLB
SCHEMBL7056291 0.94 KMT2A (0.34) KMT2AMEN1PDE5ALMNAPOLB
SCHEMBL7053379 0.94 PDE5A (0.36) KMT2AMEN1PDE5ALMNAPOLB
SCHEMBL7050684 0.90 KMT2A (0.34) KMT2AMEN1PDE5APOLBMET
SCHEMBL7050993 0.89 KMT2A (0.34) KMT2AMEN1PDE5APOLBMET
SCHEMBL7053105 0.86 PDE5A (0.34) KMT2AMEN1PDE5APOLB
SCHEMBL6476366 0.86 KMT2A (0.47) KMT2AMEN1PDE5ALMNAPOLB
SCHEMBL7053059 0.86 KMT2A (0.38) KMT2AMEN1PDE5ALMNAPOLB
SCHEMBL7053061 0.85 PDE5A (0.35) PDE5AMET
SCHEMBL7050024 0.83 S1PR3 (0.38) KMT2AMEN1LMNAPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171361-A1 Pyrrolopyrimidinone derivatives, process of preparation and use SK CHEMICALS CO., LTD. (KR) 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171361-A1 Pyrrolopyrimidinone derivatives, process of preparation and use CYP2C19, DHPS, SDHA KMT2A 4373/4885MEN1 2829/4885PDE5A 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.